Gyre Therapeutics, Inc.
GYRE • NASDAQ
Gyre Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ping Zhang, with a market cap of $619.1M.
CEOPing Zhang
Next Earnings
Upcoming earnings announcement for Gyre Therapeutics, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Revenue Estimate
$32.5M
Earnings History
Past 9 earnings reports for Gyre Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | $0.05Est: $0.04 | +15.0% | $37.2MEst: $35.8M | +3.8% |  10-K |
| Nov 7, 2025 | Q3 2025 | $0.03Est: $0.01 | +200.0% | $30.6MEst: $33.2M | -7.8% | 10-Q |
| Aug 11, 2025 | Q2 2025 | $0.00Est: $0.03 | -100.0% | $26.8MEst: $28.6M | -6.3% | 10-Q |
| May 9, 2025 | Q1 2025 | $0.00 | — | $22.1M | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | $0.00 | — | $27.9M | — | 10-K |
| Nov 13, 2024 | Q3 2024 | $0.01 | — | $25.5M | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | $0.01 | — | $25.2M | — | 10-Q |
| May 9, 2024 | Q1 2024 | $0.03 | — | $27.2M | — | 10-Q |
| Mar 26, 2024 | FY 2023 | -$1.41 | — | $113.5M | — | 10-K |